Decitabine dosage and response rates in patient subgroups
| . | 5-day IV dose . | 5-day SC dose . | 10-day IV dose . |
|---|---|---|---|
| No. of patients | 64 | 14 | 17 |
| No. of patients in CR (%) | 25 (39) | 3 (21) | 4 (24) |
| (Estimated) CR patients for the first 15 patients | (6) | 3 | 4 |
| . | 5-day IV dose . | 5-day SC dose . | 10-day IV dose . |
|---|---|---|---|
| No. of patients | 64 | 14 | 17 |
| No. of patients in CR (%) | 25 (39) | 3 (21) | 4 (24) |
| (Estimated) CR patients for the first 15 patients | (6) | 3 | 4 |
IV indicates intravenous; SC, subcutaneous.